FDA approval enables Complement Therapeutics to start the Opti-GAIN phase 1/2 trial for CTx001 in GA secondary to AMD. CTx001 is an AAV-based gene therapy delivering a truncated Complement Receptor 1 ...
CHENNAI: CM M K Stalin on Monday announced a 20 per cent bonus and ex gratia payment for ‘C’ and ‘D’ category employees working in various state-run public sector undertakings for the financial year ...
Dabang Delhi K.C. will be looking to return to the top of the table with a win over U.P. Yoddhas on Friday in the 2025 edition of the Pro Kabaddi League. Later in the day, home side Tamil Thalaivas ...
In the poster of the Sundar C directorial, Nayanthara features as the Goddess. She is seen dressed in a green silk saree and adorned with gold and diamonds. Holding the trident, , she looks equally ...
Objectives C reactive protein (CRP) is frequently normal in psoriatic arthritis (PsA) despite active disease, complicating inflammation assessment. This study aimed to evaluate alternative biomarkers ...
The Pac-12 has undergone as bigger shuffle than any other as the conference-realignment era of college athletics has shaken up countless programs around the country. Oregon State and Washington State ...
The BJP on Sunday placed a familiar southern figure into the national spotlight, naming Maharashtra Governor C P Radhakrishnan as the NDA’s candidate for the September 9 Vice-Presidential polls. The ...
Suggested remit: To appraise the clinical and cost effectiveness of pegcetacoplan within its marketing authorisation for treating primary complement 3 (C3) glomerulopathy and primary immune-complex ...
After the CVE’s program’s near-death experience in April, might the Europeans be looking for a more reliable long-term system? From this week, the global technology industry has a new database to ...
Abstract: As the demand for energy-efficient digital systems develops, circuits that limit power consumption and facilitate green communication are becoming increasingly crucial to design. This study ...
SGLT2 inhibitors were most effective for reducing HbA1c, blood pressure, and body weight, with canagliflozin showing the lowest adverse event likelihood. GLP-1 receptor agonists, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback